NYSE:ATRPackaging
How Investors May Respond To AptarGroup (ATR) Powering ENA’s Phase II Intranasal Antiviral Study
AptarGroup, Inc. recently announced that its Unidose (UDS) Powder Nasal Spray System is being used in ENA Respiratory’s Phase II clinical study of INNA-051, an investigational once-weekly nasal spray aimed at helping protect adults at higher risk from symptomatic viral respiratory infections.
The partnership underscores how Aptar’s intranasal powder delivery and moisture-protective container technologies are supporting non-vaccine approaches to respiratory disease prevention, potentially...